Koninklijke Philips N.V. (PHIA.AS)
| Previous close | 24.38 |
| Open | 24.44 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 24.01 - 24.49 |
| 52-week range | 15.94 - 28.14 |
| Volume | |
| Avg. volume | 2,513,659 |
| Market cap | 22.757B |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.83 |
| Earnings date | 29 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 12 May 2022 |
| 1y target est | 26.40 |
ZacksPhilips (PHG) Boosts Precision Diagnosis With AI Platform
Philips (PHG) boosts its Precision Diagnosis portfolio with an AI-powered ultrasound platform, strengthening its Diagnosis & Treatment segment.
PR NewswirePhilips' APAC survey highlights public support towards prioritizing environmental sustainability in healthcare and urgent action for collaboration
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced findings from its Sustainable Healthcare survey in Asia Pacific (APAC). The survey of 3,040 respondents across Australia, South Korea, Indonesia, and Thailand, conducted with research agency Kantar Profiles Network, highlights public perceptions towards environmental sustainability in healthcare. The results provide useful insights informing strategies which APAC health systems can adopt to deliver the be
GlobeNewswireDeep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients
Using AI technology to enhance assessment of heart function through cardiac ultrasound image analysis Using AI technology for automated evaluation of heart function through segmental wall motion scoring Clinical image showing how integrating AI into cardiac ultrasound provides automated segmental wall motion scoring Clinical image showing cardiac ultrasound display for image analysis enhanced through integration of AI. June 4, 2024 New FDA-cleared AI-enabled applications include the industry’s f
